Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
This preliminary retrospective study assessed patients with highly advanced hepatocellular carcinoma, exploring the efficacy and safety of concurrent atezo